AILERON THERAPEUTICS INC (ALRNXXXX)
Institutional ownership reported to the SEC as of Q3 2024, across 18 quarters.
1
Reporting holders
$754
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Hexagon Capital Partners LLC | $754 | 213 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 1 | $754 | 213 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $591 | 213 | 1 | 0 | 0 | 0.0% |
| Q3 2022 | 28 | $5.9M | 28,290,164 | 2 | 8 | 4 | 0.0% |
| Q2 2022 | 34 | $8.3M | 32,080,815 | 2 | 8 | 6 | 0.0% |
| Q1 2022 | 39 | $16.5M | 32,202,724 | 6 | 5 | 11 | 0.0% |
| Q4 2021 | 42 | $18.9M | 33,579,919 | 9 | 11 | 9 | 0.0% |
| Q3 2021 | 42 | $33.6M | 32,915,133 | 5 | 9 | 10 | 0.0% |
| Q2 2021 | 47 | $41.5M | 33,214,266 | 6 | 14 | 8 | 0.0% |
| Q1 2021 | 52 | $48.0M | 33,567,105 | 23 | 13 | 3 | 0.0% |
| Q4 2020 | 29 | $10.8M | 10,406,983 | 11 | 5 | 4 | 0.0% |
| Q3 2020 | 25 | $3.6M | 2,791,017 | 8 | 7 | 3 | 0.0% |
| Q2 2020 | 27 | $4.6M | 3,940,725 | 14 | 6 | 2 | 0.0% |
| Q1 2020 | 17 | $652.0K | 1,956,000 | 2 | 3 | 7 | 0.0% |
| Q4 2019 | 16 | $1.0M | 1,760,725 | 2 | 3 | 2 | 0.0% |
| Q3 2019 | 18 | $2.4M | 3,536,991 | 3 | 4 | 4 | 0.0% |
| Q2 2019 | 19 | $5.2M | 7,229,430 | 4 | 6 | 4 | 0.0% |
| Q1 2019 | 20 | $12.3M | 6,377,599 | 7 | 4 | 6 | 0.0% |
| Q4 2018 | 20 | $1.1M | 1,360,119 | 2 | 1 | 1 | 0.0% |